<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Retrospective analysis of peripheral t-cell lymphoma patients: single center 'real-life' experience

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Özbalak, Murat

Mastanzade, Metban

Özluk, Özden

Tiryaki, Tarık Onur

Hindilerden, İpek Yonal

Yenerel, Mustafa Nuri

Altay, Ali Yılmaz

Yeğen, Gülçin

Nalçacı, Meliha

Beşışık, Sevgi Kalayoğlu

Date

Language

Embargo Status

No

Journal Title

Journal ISSN

Volume Title

Alternative Title

Çevresel T-hücreli lenfoma hastalarının geriye dönük değerlendirmesi: tek merkez ‘Gerçek-Yaşam’ deneyimi

Abstract

Objective: Peripheral T-cell lymhomas (PTCLs) represent a heterogeous group of diseases, with poor long-term outcomes excluding ALK+ anaplastic large cell lymphoma (ALCL). Method: We represent data of our retrospective analysis of 62 consecutive PTCL cases diagnosed since 2002. Median observation time was 16 months. Results: The overall response rate to first line treatment was 53 percent. Data related to median progression-free survival and overall survival times could not be obtained for ALK+ALCL group whereas median progression-free survival and overall survival times for ALK-negative ALCL group were 1 and 18 months, respectively. Disease progression was frequently observed histologically in ALK-negative group. For ALKnegative ALCL, advanced stage disease was defined as the presence of serum albumin <3.4 g/dl, serum total protein <= 6.2 g/dl, high serum LDH, and serum ferritin >200 ng/ml, presence of B symptoms, and extranodal involvement of more than one site. Risk factors associated with death were serum albumin <3.4 g/dl, serum total protein <= 6.2 g/dl, serum ferritin over 200 ng/ml, and bone marrow involvement at the time of diagnosis. During follow-up 39 patients (64%) died. Most common reasons were progressive disease and infections. Four patients developed secondary malignancies. Conclusion: Our study is a reflection of the 'real-life'. Three patients died due to disease progression shortly after diagnosis without providing treatment due to aggressiveness of the disease. Alternatives to CHOP-based chemotherapies should be found for the ALK + non-anaplastic large cell lymphoma group.

Source

Publisher

Galenos Publishing

Citation

item.page.haspartof

Source

Medical Journal of Bakırköy

item.page.ispartofseries

item.page.edition

DOI

10.5222/BMJ.2020.28290

item.page.datauri

item.page.link

Rights

CC BY-NC (Attribution-NonCommercial)

Copyrights Note

Creative Commons license

Except where otherwise noted, this item's license is described as CC BY-NC (Attribution-NonCommercial)

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators